Levels of phosphorylated mTOR, NF-κB, PD-L1 and Ki-67 (a marker of tumor proliferation) were also reduced following SLC6A14 inhibition (Fig. 6f, g and Supplementary Fig. 6c). The gene discussed is MTOR; the disease is neoplasm.